Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 494Lymphoma 52Recurrence 49Neoplasms, Plasma Cell 49Immunoglobulin Light-chain Amyloidosis 43Neoplasms 35Lymphoma, Non-Hodgkin 35Leukemia 34Hematologic Neoplasms 32Myelodysplastic Syndromes 28Smoldering Multiple Myeloma 27Leukemia, Myeloid, Acute 26Leukemia, Plasma Cell 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Monoclonal Gammopathy of Undetermined Significance 18Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 17Amyloidosis 17Lymphoma, B-Cell 15Breast Neoplasms 14Ovarian Neoplasms 12Paraproteinemias 11Myeloproliferative Disorders 10Colorectal Neoplasms 10Primary Myelofibrosis 9Melanoma 9Lymphoma, Follicular 9Infections 9Prostatic Neoplasms 8Lymphoproliferative Disorders 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thalassemia × Plasma cell × Clear all
NCT06250595 2024-02-09

ENROL

Hospital Universitari Vall d'Hebron Research Institute

Recruiting
37,090 enrolled
Classical hematologyOther hematologic neoplasmPlasma cell

Bone Marrow Failure Disorders, Anemia, Anemia, Sickle Cell, Leukemia, Thalassemia, Iron Metabolism Disorders, Hematologic Neoplasms, Hemostatic Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡